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Abstract
Background: Effective implementation of rapid point of care tests (POCTs) for antenatal syphilis screening especially in
settings where antenatal care attendance is high, can significantly increase screening coverage and treatment uptake.
The operational challenges of introducing rapid syphilis POCTs at scale needs to be investigated. This study explores
healthcare providers’ experiences and challenges in antenatal syphilis screening following the national rollout of rapid
syphilis POCTs in Ghana.
Methods: Prior to the main study, we undertook a desk review of key syphilis policy documents, and conducted key
stakeholder interviews and a baseline survey of syphilis screening practices. Antenatal syphilis screening had been poorly
implemented mainly due to inadequate technical and logistic support, and lack of monitoring and supervision. For the
main research, semi-structured interviews were conducted with 51 purposively selected healthcare staff involved in
antenatal syphilis screening in 15 health facilities in three regions, representative of all levels of healthcare in Ghana and
two regional programme coordinators, at least four months after the rollout. The interviews were supplemented with an
audit of the conduct of antenatal care, syphilis-related supplies and other maternal and newborn interventions. Qualitative
data were coded and analysed using Nvivo software.
Results: Syphilis screening with rapid POCTs was integrated into antenatal care in almost all (13/15) the facilities
surveyed. Testing and treatment were offered free of charge to pregnant women, their partners and babies. In
most facilities, midwives were performing syphilis tests together with HIV tests. Operational challenges included:
inadequate training and lack of refresher training, lack of clear testing guidelines, clear channels of communication,
supervision, and guidance on treatment and referral procedures, frequent stockouts of, or expired test kits, staff overload,
and poor documentation of test results and treatment.
Conclusion: Although syphilis screening with rapid syphilis POCTs was integrated into antenatal care, key challenges,
particularly around supply chain and supervision, need to be addressed to improve and sustain such a programme.
Keywords: Rollout, Health care providers, Point of care tests (POCTs), Antenatal syphilis screening, Ghana
* Correspondence: edidassah@yahoo.com
1School of Public Health, Kwame Nkrumah University of Science and
Technology, Kumasi, Ghana
2Department of Obstetrics and Gynaecology, Komfo Anokye Teaching
Hospital, Kumasi, Ghana
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dassah et al. BMC Health Services Research  (2018) 18:130 
https://doi.org/10.1186/s12913-018-2935-y
Background
Globally, over half a million entirely preventable perinatal
deaths are attributable to maternal syphilis each year [1].
These adverse pregnancy outcomes can be averted through
effective screening and treatment of women who are posi-
tive for syphilis during pregnancy [1]. However, even in
countries where antenatal care (ANC) coverage is high and
antenatal syphilis screening exists as a national policy,
routine screening may not be well implemented at scale,
commonly due to the organisation of health services,
operational challenges and cost of syphilis testing [2].
Recent studies on the use of rapid syphilis point of
care tests (POCTs) for antenatal syphilis screening in
clinic settings have demonstrated that these tests can
effectively increase screening coverage and treatment
uptake [3].
National reproductive health policy promotes syphilis
screening as an integral component of ANC in Ghana [4].
However, antenatal syphilis screening had been poorly im-
plemented and pregnant women in many antenatal clinics
were not being screened and treated for syphilis [5]. For
example, only 4% of health facilities nationwide offered
syphilis testing as a routine component of ANC and labora-
tory tests for syphilis were not widely available [6]. About
three quarters of health care providers in the Greater Accra
and Central regions did not have basic training on syphilis
screening and providers’ knowledge of the management of
syphilis in pregnancy was particularly low [7]. Reasons cited
for the poor implementation of the policy included; poor
dissemination and inadequate guidance for implementa-
tion, lack of training, and insufficient logistic support [5, 7].
Consequently, following reported dramatic increases
in maternal syphilis seroprevalence during sentinel surveil-
lance, the Ghana Health Service (GHS) rolled-out rapid
syphilis POCTs for routine antenatal screening in public
healthcare facilities throughout the country from October
2009. The tests and treatment are offered completely free
of charge to pregnant women, their partners and babies.
Antenatal care attendance is high in Ghana (76% for at least
4 visits, and 96% for at least one visit) [8], suggesting that
effective implementation of rapid syphilis POCTs and treat-
ment of seropositive women during pregnancy can prevent
the consequences of maternal syphilis.
While rapid POCTs are expected to increase syphilis
screening and treatment coverage, the operational chal-
lenges of introducing syphilis POCTs at scale have not
been investigated. In this study, we present the perspec-
tive of healthcare providers in public health facilities in
selected regions of Ghana in relation to their experiences
and challenges following a national rollout of rapid syphilis
POCTs in Ghana. We sought to determine if previous
known challenges were addressed, and also identify any
new challenges associated with the current rollout at the fa-
cility level. The performance of the programme was also
compared with three other recommended antenatal inter-
ventions, namely prevention of mother-to-child transmis-
sion (PMTCT) of HIV, intermittent preventive treatment of
malaria in pregnancy (IPTp), and prevention of maternal
and neonatal tetanus (tetanus toxoid), as tracer control
interventions. The results of the study were meant to inform
national policy of challenges in the existing programme
that needed to be addressed to improve antenatal syph-
ilis screening coverage with POCTs and treatment of
seropositive cases.
Methods
Baseline survey and study context
Prior to the main research, a baseline survey of key syphilis
policy documents, stakeholders and syphilis screening prac-
tices was carried out by one author, ETD. This formative
research was conducted to assess the existence of a national
policy for, and practise of antenatal syphilis screening in
Ghana prior to the national rollout of syphilis POCTs.
Semi-structured interviews were conducted with 15
stakeholders who were purposively selected from nine
organizations at the national level including various
divisions/programmes of the GHS and Ministry of Health,
and some multilateral agencies relevant to sexually trans-
mitted infection (STI) control and policy implementation.
Within each organization, the director, manager/coordin-
ator or senior technical advisor was interviewed. A desk
review of syphilis policy documents was also undertaken
during this phase of the research.
The desk review and key stakeholder interviews indi-
cated that syphilis screening had been a long-standing
component of antenatal care in Ghana, and an integral
part of the reproductive health policies of the country
since 1996. The policy mandates that all pregnant should
be screened for syphilis during antenatal care [4, 9]. How-
ever, at the time of this baseline survey, implementation
had been poor and screening had not been routinely prac-
tised in many antenatal clinics due to several challenges.
These included under-appreciation of the problem of
syphilis, lack of confidence in the current surveillance
strategy, confusion over responsibilities for antenatal syph-
ilis control due to poor collaboration between complemen-
tary agencies, insufficient logistic and technical support,
poor documentation and lack of indicators for monitoring
and evaluation.
A rapid audit was undertaken in 10 facilities in three
regions, Central, Ashanti and Northern Regions. Only 3
of the 10 facilities routinely screened pregnant women
for syphilis. In these facilities, pregnant women were re-
ferred to the laboratory within the facility, where blood
samples were taken and syphilis testing done using POCTs.
The 3 facilities used different kinds of POCT kits, pur-
chased individually from allocated funds. Stockouts of
POCTs was rare. Two of the facilities were in the Central
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region, and routine testing had been introduced prior to
the national rollout due to the persistent high prevalence
of syphilis during the national HIV/syphilis sentinel
survey. Only one tertiary facility had equipment to per-
form conventional syphilis testing with rapid plasma
reagin (RPR) or Venereal Disease Research Laboratory
(VDRL) tests, and also regularly stocked benzathine penicil-
lin for syphilis treatment. Syphilis test results were routinely
documented in the ANC registers of the 2 facilities in the
Central Region. There was no column in the register for
recording treatment. None of the facilities had specific
syphilis screening and treatment guidelines.
Selection of regions and health facilities
We conducted a qualitative research aiming to be inclusive
of all health regions of Ghana and to be representative of
all levels of health service delivery in the country. We there-
fore designed a multilevel purposive sampling frame. A de-
tailed description of the selection of the regions, districts
and health facilities has been given elsewhere [10]. Briefly,
the Central, Ashanti and Northern Regions (the same re-
gions that were selected for the baseline survey) were pur-
posively selected to reflect high, moderate and low syphilis
seroprevalence regions respectively, since antenatal syphilis
screening practices could be influenced by reported syphilis
seroprevalence. The reported syphilis seroprevalence were
based on the 2004–2009 HIV/syphilis sentinel surveys.
Altogether 15 health care facilities were selected across the
different levels of health care delivery in the three regions.
The study is reported according to the consolidated criteria
for reporting qualitative research (COREQ) [11].
Healthcare provider interviews and audit of the conduct
of ANC
Face-to-face semi-structured interviews were conducted
in English between four and fifteen months after the
syphilis POCT rollout had occurred (from August 2010
to February 2011) with purposively selected healthcare
staff involved in antenatal syphilis screening in each of
the 15 health facilities and regional STI coordinators,
after obtaining written informed consent. The staff included
doctors, physician assistants, midwives, pharmacists/dis-
pensing technicians and laboratory scientists. Within each
health facility, the head of the facility or Obstetrics and Gy-
naecology department (for regional and teaching hospitals),
unit head for maternity and/or a midwife from the ante-
natal clinic, a laboratory technician and a pharmacist or
dispensing technician were purposively selected for inter-
view. The midwives and laboratory personnel performed
antenatal syphilis screening using POCTs. The pharma-
cists/dispensing technicians were chosen to assess issues
relating to availability and stock levels of benzathine peni-
cillin. The facility or unit heads (medical superintendents,
physician assistants or midwives) and doctors involved in
STI management (medical officers) were selected because
of their role in the training, supply and use of syphilis
POCTs and treatment of syphilis seropositive cases. All
interviews were conducted within the health facilities or
offices by one author (ETD), who was a medical practi-
tioner in one of the teaching hospitals, and knew some of
the participants. Each interview lasted between 7 and
40 min, depending on the role of the provider in ante-
natal syphilis screening and treatment. Generally, inter-
views with the pharmacists/dispensing technologists
were the shortest, while those with the midwives and
medical officers tended to be much longer. The interviews
focused on the training of staff in syphilis screening and
management, supply of test kits and drugs, guidance on
testing procedures and treatment protocols, documentation
of test results and treatment, monitoring and supervision,
barriers and challenges to antenatal syphilis screening and
ways of improving and sustaining the programme, as well
as other recommended national prenatal interventions such
as PMTCT of HIV, IPTp and prevention of maternal and
neonatal tetanus for comparison as tracer control interven-
tions. The interview guide was developed after a review of
the literature, study objectives and research questions and
discussion among the research team. All interviews were
digitally recorded and supplementary written notes taken
as necessary. One staff from each of the selected categories/
units in each facility, who was available, was approached for
interview and agreed to participate in the study. There
was no attempt to stop at theoretical saturation, since
we intended to obtain experiences of healthcare providers
across the different levels of reported syphilis seropreva-
lence and healthcare delivery in the country.
In addition, an audit of the conduct of ANC and a
comprehensive inventory of testing, treatment and refer-
ral guidelines, and stock levels of test kits and treatment
supplies for syphilis and the control tracer interventions
(including needles and syringes, benzathine penicillin,
erythromycin, nevirapine, sulphadoxine pyrimethamine and
partner notification cards) was conducted. Two structured
observations of the content of health education during
ANC, site and timing of syphilis testing (antenatal clinic,
onsite laboratory or offsite laboratory), as well as the man-
agement of syphilis seropositive cases (including counsel-
ling, provision of results and treatment given to clients,
their contacts and babies) were carried out in each facility.
The availability of syphilis screening and management re-
lated guidelines and protocols was also assessed and com-
pared with other recommended antenatal interventions.
Data management and analyses
Audio recordings were transcribed verbatim on each day
of the interview after returning from the field. Transcripts
were explored through multiple readings for accuracy
and familiarization; a priori themes, key issues, concepts,
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emerging and recurrent themes were noted at this stage.
Predefined themes were developed based on review of the
literature, the research objectives and questions and prelim-
inary review of the interview transcripts. The transcripts
were then imported into NVivo 8 (QSR International Pty
Ltd., Melbourne, Australia), coded and analysed in detail
using framework analysis [12]. One script was independ-
ently coded line by line by two authors. They then dis-
cussed any discrepancies and reached a consensus on
the codes to be used for the other transcripts. The rest
of the transcripts were then read thoroughly and coded
accordingly while paying attention to any new codes
that emerged. The codes were then grouped under our
predefined themes. The results are presented according
to the major themes and sub-themes. Proportions were
calculated in percentages for various categories of struc-
tured observations, guidelines and stock levels of supplies.
Trustworthiness
To increase the trustworthiness of the study, we triangu-
lated the information obtained from the various healthcare
providers by comparing their experiences across facilities.
We also held a peer-debriefing between all authors to
discuss the coding process, categories and interpretation of
the study data.
Research ethics
Written informed consent was obtained from all partici-
pants including their consent to record the interviews and
also quote them. Participation in the study was entirely
voluntary and participant anonymity was maintained
throughout the processes of interview transcription, data
analysis and presentation. The study was approved by the
Ghana Health Service Ethical Review Committee and the
Committee on Human Research, Publications and Ethics,
Kwame Nkrumah University of Science and Technology,
Ghana, and the Ethics Committee of the London School
of Hygiene and Tropical Medicine, United Kingdom.
Results
Fifty-one healthcare providers in the 15 healthcare facil-
ities and two regional STI coordinators were interviewed
(Table 1); one regional STI coordinator was not available
for interview during our visit to that region and could
not be contacted afterwards. Antenatal syphilis screening
was decentralised to almost all (13/15) the public facil-
ities surveyed. Operational challenges identified included
inadequate training, lack of testing guidelines and treat-
ment protocols, frequent stockouts or expired test kits,
staff overload, inadequate monitoring and supervision,
and issues with documentation of test results and treat-
ment. A summary of the major themes and subthemes,
and key findings are summarised in Table 2.
Uptake and successes
With the exception of two health centres in Region 3, all
other facilities (13/15) were performing syphilis tests for
pregnant women. Although staff in the two facilities were
trained to perform the tests, they had never started the
testing either because they were not supplied with any test
kits or the initial consignment of test kits they got were all
expired before any testing could commence:
“I was trained last year [2009]… I have never done the
test [for pregnant women]… They gave us the test kits
but when we realized that they were all expired, I sent
them back [to the regional medical stores]… We made
a request and they said anytime they receive some
[test kits] they will supply us.” (Midwife)
All 13 facilities were using the same syphilis POCT, i.e.
Determine syphilis TP (Abbott Japan Co Ltd., Tokyo, Japan)
that was supplied by the National AIDS/STI Control
Programme and distributed through the regional med-
ical stores. Midwives were performing syphilis tests
for pregnant women at the antenatal clinic in all but
three facilities (in Region 3), where syphilis testing was
done at the laboratory within the facility. Interestingly,
while HIV tests for pregnant women were done at the
Table 1 Regions and level of healthcare facilities selected and
healthcare workers interviewed
Level of facility and staff Number of facilities and staff
selected in each region
Ashanti Central Northern Total
Level of facility
Teaching or Regional Hospitala 0 1 1 2
District or Main Hospital 3 2 2 7
Private Hospital or Health Centre 2 2 2 6
Total 5 5 5 15
Healthcare staff
Regional STI Coordinatorb 1 1 0 2
Medical Superintendents/
Medical Officers
3 5 3 11
Medical Assistants 1 2 1 4
Midwives 6 7 5 18
Laboratory Scientists 4 3 3 10
Pharmacists/Dispensing
Technicians
4 1 3 8
Total 19 19 15 53
STI, sexually transmitted infection
aThe teaching and regional hospitals in the Ashanti region were not selected
because: Syphilis test results were not routinely documented in the antenatal
care register at the teaching hospital, and antenatal care attendance in the
regional hospital was much lower than that of the selected district hospital.
bThe regional STI coordinator for the Northern Region was not available for
interview during our visit to the region
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antenatal clinic in the three facilities, insufficient staff
cadre was cited as the reason for the inability to perform
syphilis tests at the antenatal clinic in those facilities.
The main successes of the rollout programme were
reported to be easy integration of syphilis screening into
ANC services and its decentralisation to most public
health facilities. Antenatal syphilis testing and treatment
were offered free of charge to all pregnant women, their
babies and partners. Decentralisation of testing to public
facilities at all levels of the healthcare delivery system
was perceived as a relief to many rural women who
could not afford the cost of travel to larger facilities such
as the regional hospital when they were referred for
testing:
“The decentralisation has been very helpful. Hitherto
patients were travelling far to, say, the regional
hospital [more than 120km away] to go and have
these tests done and failed to go because of cost [of
travel]; so decentralization is the best...” (Medical
superintendent)
Some midwives were advocating that syphilis testing
and treatment should be extended to the private mater-
nity homes since they attend to a considerable number
of pregnant women especially in rural settings:
“...instead of referring them to major health centres it
should be done at every clinic including the private
Table 2 Thematic framework, personnel interviewed and key findings of investigation of syphilis POC testing policy in Ghana
Themes and sub-themes Personnel interviewed Key findings
1. Uptake and successes
• Syphilis testing for pregnant women Facility in-charges, midwives
and laboratory technologists
Almost all facilities were performing syphilis tests for
pregnant women either at the antenatal clinic or laboratory
Two facilities could not start syphilis testing due to lack
of/expired test kits
• Successes Facility in-charges, midwives,
pharmacists and laboratory
technologists
Decentralisation of syphilis testing
Free syphilis testing and treatment for pregnant women
2. Staff training and facility level preparedness for rollout of treponemal POCTs
• Awareness of policy on antenatal
syphilis screening
Facility in-charges, medical
officers and midwives
All respondents aware of the need to screen all pregnant
women for syphilis
• Knowledge of consequences of
untreated maternal syphilis
Facility in-charges, medical
officers and midwives
Almost all staff knew of an adverse pregnancy outcome
due to maternal syphilis
Considered knowledge of the consequences of untreated
maternal syphilis to be essential in counselling
• Training and retraining in the use
of treponemal POCTs
Facility in-charges, midwives,
laboratory technologists and
STI coordinator
Midwives trained in all facilities
Issues with quality of training (compared to HIV training):
duration, content, practical demonstration and interpretation
of test results
Lack of standard operating procedures
No re-retraining/refresher training after the initial training
• Antenatal syphilis screening, treatment
and referral guidelines
Facility in-charges, midwives,
lab technologists and STI
coordinator
No guidelines for antenatal syphilis screening
Syphilis treatment protocols available in only two facilities
No referral guidelines for syphilis screening and treatment
Screening and treatment guidelines/protocols for other
maternal and newborn interventions displayed at vantage
points in facilities
No partner notification cards/slips for STIs (including syphilis
& HIV)
3. Staff experiences and challenges
• Maternal syphilis as a component of
health education during pregnancy
Midwives All but one facility discussed maternal syphilis during health
education sessions for pregnant women
• Experience of performing HIV and
syphilis tests together
Midwives Easier and time saving for healthcare providers
Good counselling required for a clear understanding and
interpretation of HIV and syphilis test results
Convenient for pregnant women
• Challenges All Stockouts of syphilis test kits and benzathine penicillin
Inadequate staff/work overload
Poor documentation of syphilis test results and treatment
Lack of supervision and quality checks
ANC - Antenatal care; POCT – Point of care test; STI - Sexually transmitted infection
Dassah et al. BMC Health Services Research  (2018) 18:130 Page 5 of 12
midwives, since most pregnant women also visit these
midwives.” (Midwife)
Staff training and facility level preparedness for the
rollout of syphilis POCTs
Healthcare staff generally agreed that it was a requirement
of the GHS that “…all pregnant women should be screened
for syphilis during antenatal care…” and stated that such a
policy had been in existence for several years. Almost all
staff knew of at least an adverse pregnancy outcome asso-
ciated with untreated maternal syphilis. They contended
that knowledge of syphilis was necessary in counselling
pregnant women to take up syphilis testing. As one mid-
wife explained:
“…because I tell them the consequences [of maternal
syphilis] and how the baby can be affected just as
in HIV… they are willing do it [syphilis test]...”
(Midwife)
Midwives were trained in the use of syphilis POCTs in
almost all of the health facilities surveyed. The training
was commonly done during HIV testing workshops/
review meetings but the form and quality of training varied
across districts and regions. In some regions, laboratory
personnel were trained at the regional level and the vari-
ous District Health Management Teams (DHMTs) tasked
with organizing training for the midwives at the district or
facility level:
“We did our initial training at the regional level when
we were doing the PMTCT and encouraged the
DHMTs to arrange for the antenatal service providers
to be trained by the lab [laboratory] men and scale
up... So this was a package to retrain the lab personnel
who will in turn train the midwives.... In one district,
the lab men came to the District [Health] Directorate
and organized a training session for other staff that
had not been trained.” (STI coordinator)
However, some midwives expressed concern about the
quality of the training they received for syphilis testing
compared to that of HIV testing especially as they were
required to train their colleagues at the various facilities.
These midwives did not feel very confident to train other
healthcare providers as they considered the training to
be short in duration, inadequate in content and lacked
practical demonstration of the testing process and inter-
pretation of the test results. Nonetheless, these midwives
carried out these training sessions:
“I was not really trained... it was at a [HIV] review
meeting that I was given some tit bits... I won’t call
that training! But when I came I taught others; the
community health nurse and others now know how to
do the tests...” (Midwife)
The inadequacies of some of the training sessions were
corroborated by some laboratory scientists who were
involved in the training. Yet, about one year after the
initial training, none of the midwives had been retrained
and there did not seem to be any plans for such refresher
courses. Healthcare providers advocated for adequate train-
ing and regular retraining to update their skills. As one la-
boratory technologist summarised:
“I think the midwives should be well trained...because
anybody at all can decide to do the test... and that can
affect the patient. At least once a while, we should
retrain those actually doing the tests.” (Laboratory
technologist)
There were no clear guidelines or documents available
to midwives on syphilis testing, how to perform the tests,
on which subpopulation and when, in any of the facilities
visited. However, various guidelines for other maternal and
newborn interventions were displayed in most facilities; 11/
15, 12/15 and 14/15 of the facilities had HIV testing, IPTp
and tetanus toxoid administration guidelines, respectively
(Table 3). These guidelines were similar across facilities
and were mostly from the GHS. The lack of screening
and management guidelines for syphilis was corrobo-
rated by one regional STI coordinator:
“We have [screening and treatment guidelines] for HIV
but we do not have specific guidelines for syphilis.”
(STI coordinator)
Only two facilities had treatment protocols for syphilis,
one of which also had a protocol for management of
neonates (Table 3). Prophylactic treatment was only offered
to babies of syphilis seropositive women in the facility with
the protocol for neonates. Although most healthcare pro-
viders knew of benzathine penicillin as the treatment of
choice for syphilis in adults, they could not recall the
exact dosage, and were not aware of any national treatment
guidelines for syphilis. Consequently, treatment regimens
varied from one facility to the other; ranging from a single
intramuscular dose of 2.4 M units through three doses
given at weekly intervals, to seven doses (single dose daily
for 7 days). There were no protocols for managing penicil-
lin allergy, neither were there partner notification cards for
STI management including syphilis and HIV (Table 3).
There were no referral guidelines for syphilis screening
and treatment and pregnant women were hardly referred
from one facility to the other for testing or treatment.
Similarly, no referral guidelines were available in facilities
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that were not offering antiretroviral treatment for HIV.
Conversely, IPTp and tetanus toxoid were administered in
all facilities and there was no need for referral to other
facilities for these interventions.
Staff experiences and challenges
In all but one facility (where pregnant women were not
being screened for syphilis), maternal syphilis was discussed
as part of the health education offered during ANC. Other
maternal and newborn interventions such as PMTCT
of HIV, prevention of malaria in pregnancy and neonatal
tetanus were discussed routinely during ANC in all facil-
ities. Health education sessions were conducted in the local
dialects, were interactive and preceded any individual coun-
selling, testing or treatment. Midwives noticed that most
pregnant women readily opted for counselling and testing
for syphilis especially after a good health education session:
“We give them health education talks in Twi
[vernacular] and this helps them to understand.
Following this most of the women then come for the
test because of the explanation we give them... when
we educate the women nicely, they come and do the
test.” (Midwife)
Most training programmes emphasized the need to do
HIV and syphilis tests together at the antenatal clinic.
The majority of the midwives who did the two tests to-
gether acknowledged it was convenient for the client (one
instead of two needle pricks and queuing once instead of
twice), human resource sparing and time saving for health-
care providers (one person doing the two tests at the same
time thus using less time than would be required by
two different individuals to do the two tests separately)
and quite easy (tests procedure and interpretation very
much similar), and advocated the practice should be
encouraged. One midwife shared her experience of doing
the two tests simultaneously:
“I have not had any problems because we counsel
them well. ...what I do is that I prick the women once
and put a drop of blood each on the syphilis and HIV
test strips add their buffers and wait for the results...
They understand because I explain everything to them
before I do the test... Sometimes they ask a lot of
questions... No they will not get confused [with HIV and
syphilis results]... it is easy [to do the two tests together]
and we should do them at the same time.” (Midwife)
Structured observations made during our visits showed
that pre-test counselling for HIV or syphilis were generally
satisfactory; staff were friendly, gave explanations as
necessary and allowed clients to seek clarifications. However,
management of the few syphilis- or HIV-seropositive
women (two syphilis- and three HIV-seropositive women)
during our visits could generally be described only as “fair”
as most of the issues related to providing comprehensive
treatment such as eliciting symptoms and risk factors,
undertaking partner notification, and prophylactic treat-
ment for the baby at birth were not discussed in sufficient
detail.
Within three months of starting syphilis screening, most
facilities (8/13) had to suspend testing for 1–3 months due
to “expired test kits” and to a lesser extent stockouts (of
Table 3 Availability of screening/treatment protocols and referral guidelines for antenatal and neonatal interventions
Number of facilities
Management Protocol/Guideline Available, displayed Available, not displayed None available
Screening and treatment guidelines/cards (N = 15)
Syphilis screening guidelinesa 0 0 13
HIV screening guidelines 8 3 4
Malaria IPT administration guidelines 11 1 3
Tetanus toxoid administration guidelines 13 1 1
STI partner notification cards (HIV & syphilis) 0 0 15
Syphilis treatment protocols/cards (N = 13)a
Treatment protocol for seropositive mothers 1 1 11
Treatment protocol for babies of seropositive mothers 1 0 12
HIV treatment protocols and referral guidelines
Treatment protocol for seropositive mothers (n = 8)b 8 0 0
Treatment protocol for babies of seropositive mothers (n = 8)b 7 1 0
Referral guidelines for treatment of seropositive mothers (n = 7)c 0 0 7
Referral guidelines for treatment of babies of seropositive mothers (n = 7)c 0 0 7
STI, sexually transmitted infection; a2 facilities that had not started screening pregnant women for syphilis were excluded; b7 facilities that were not offering
antiretroviral treatment for HIV were excluded; c8 facilities that were offering antiretroviral treatment for HIV were excluded
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unexpired test kits). Some facilities had barely started using
the test kits at antenatal clinic when they had to suspend
testing. This was recognised at the facility and regional
levels, and largely attributed to the procurement system:
“We started testing [at the antenatal clinic] towards
the end of June [2010] and stopped early July [2010]...
The test kits that we had got expired, so we could not
continue... I tried [contacted] the [medical] stores but I
could not get any.” (Midwife)
“…The first one [challenge] has to do with the supply of
[syphilis] test kits, which as I have already mentioned, is
erratic. Another problem is that the time between
receiving these commodities and the expiry dates is so
short. Sometimes we get [syphilis] test kits that are
expiring within six months… I think it’s the interval of
ordering. Sometimes they order them and by the time
they reach here and are supplied they are almost
nearing expiring dates.… I think the whole problem has
to do with the procurement system.” (STI coordinator)
From our stock audits, almost half (6/13) of facilities
which had started antenatal syphilis screening did not
have any syphilis test kits while HIV test kits were available
in all the 14 facilities that were screening pregnant women
for HIV (Table 4). In some facilities, stockouts of syphilis
test kits were quite frequent but pregnant women were
not referred to other facilities for testing, and were only
screened when the test kits became available. In one region,
while healthcare providers blamed stockouts of test kits on
inadequate supplies from the regional level, staff at the
regional directorate blamed it on the lack of returns from
the districts and healthcare facilities (facilities are required
to submit periodic returns/reports on all supplies provided
to them), and less commonly insufficient supplies from the
Central level (national headquarters):
“We [at the Regional Health Directorate] have not
received any feedback; I have a problem here because
they should have sent us returns indicating how many
test kits have been used, how many got expired. They
should have made contact with their facility heads
who will in turn contact the District Director [of
Health Services] and then the region will be informed.
I don’t think we have to wait for Accra [National AIDS/
STI Control Programme] to supply us... none of them
[facilities] gave us information on shortages or expired
kits, and once expired, the expired kits need to be
returned to the regional medical stores so that feedback
can be given to the national level.” (STI coordinator)
On the other hand, stockouts of benzathine penicillin
were uncommon. Only one hospital reported stockouts,
but was not aware that requisition had to be made on a
special form, as the drug was regarded as a “programme
drug” (i.e. meant for only the syphilis programme) at the
regional level and healthcare facilities ought to have been
informed accordingly. Unfortunately, pregnant women with
a positive syphilis serology had to purchase benzathine
penicillin on their own from private shops within the
period of the stockout.
Our audit revealed that almost half (6/13) of the facilities
had not been supplied with benzathine penicillin since rou-
tine syphilis testing started. Some facilities (5/13) had also
not been given erythromycin as alternative treatment in
cases of penicillin allergy. On the other hand, nevira-
pine was available in all facilities that offered prophy-
lactic treatment to babies of HIV seropositive mothers.
Sulphadoxine pyrimethamine for IPTp was lacking in
only two facilities and stockouts of needles and syringes
were less common (Table 4).
Staff numbers were considered to be insufficient in most
facilities, and midwives complained of increased workload
especially when they had to complete additional registers or
do extra “paper work”:
“...a lot of writing; filling the insurance [National
Health Insurance forms], antenatal book, registers,
prescription etc and that consume a lot of time. So
we need more staff...” (Midwife)
Nevertheless, most midwives considered syphilis test-
ing as an integral part of their duty, and were willing to
Table 4 Stock levels of test kits, lancets, drugs and needles and
syringes for HIV and syphilis testing and treatment
Consumables Stock levels
Nil < 1 month ≥1 month
Test kits and lancets
Syphilis test kits (n = 13)a 6 0 7
Syphilis test kits-chase buffer (n = 13)a 6 1 6
HIV test kits/diluent (n = 14)b 0 4 10
Lancets (n = 15) 1 0 14
Drugs and needles and syringes
Injection Benzathine penicillin (n = 13)a 8 1 6
Tablets Erythromycin (n = 13)a 7 0 8
Syrup Nevirapine (n = 8)c 0 2 6
Tablets Sulphadoxine pyrimethamine
(n = 15)
2 1 12
Needles and syringes (n = 15) 1 0 14
a2 facilities which had not started syphilis screening were excluded; b1
facility which had not started antenatal HIV screening was excluded; c7
facilities that were not offering antiretroviral therapy (nevirapine) to
babies of HIV positive mothers and referred all babies to other facilities
for treatment were excluded
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do the tests. In a few “one healthcare provider” stations,
clients had to spend long waiting times for their turn to
do the test or the test could not be offered at all times.
Although most midwives were willing to do the tests,
both the facility managers and midwives agreed that it
was necessary to encourage and motivate the midwives
for the “extra work” being done to ensure that the spirit
and enthusiasm with which they started the testing did
not die down. Money was commonly suggested as the
form of motivation; other suggestions were commendation
for good work, training workshops, gifts, print or electronic
material on syphilis, and uniforms or polo shirts. Generally,
it was agreed that motivational packages could be funded
from internally generated funds and given monthly, quar-
terly, half-yearly or yearly:
“Motivation must not always be financial; any package
that will show appreciation for the good work being
done like citation and further training will motivate
them to improve upon their performance... These can
even be given at the end of the year.” (Medical assistant)
All four prenatal interventions were routinely recorded
in the maternal record booklets in all facilities, but record-
ing in the antenatal care registers was very variable. There
was no column in the antenatal care register for recording
syphilis treatment. In some instances, midwives complained
of “too much” documentation, partly due to the existence of
multiple registers for different programmes for example
different registers for recording HIV results, tetanus toxoid
and IPTp.
No quality control programme or monitoring and super-
visory visits were instituted to monitor the progress of the
programme. These were all proposed by healthcare pro-
viders during our study. Significantly, midwives felt the
need for their testing to be supervised and laboratory
personnel were also happy to provide internal checks:
“...Once in a month there should be some quality
control checks; we have positive and negative
samples, we can take them to the clinic for the
midwives to use their kits on... Occasionally we can
also pass-by and see what the midwives are doing.”
(Laboratory technologist)
Healthcare providers were quite enthusiastic about new
dual POCT kits, i.e. combining HIV and syphilis tests, or
treponemal and non-treponemal tests in the same testing
cassette. The former will enhance the integration of screen-
ing for both infections into ANC, while the latter, by
distinguishing active syphilis infections from past/treated
syphilis infections or individuals without syphilis infection
will streamline treatment. The providers presumed that
these newer kits would be easy to use and if offered free of
charge, would be particularly helpful at antenatal clinics.
Apart from saving staff and clients’ time, these tests would
also prevent the need for multiple needle pricks or blood
samples, especially when midwives forget to take blood
specimen for one test or the other. As one midwife put it:
“It will be helpful. Sometimes you forget you are going
to do the syphilis test after you have taken the blood
drop for HIV. So after the HIV test you have to prick
the woman again. So if the two tests are on the same
test kit you will remember to do the two [tests] at the
same time” (Midwife)
Discussion
This study focused on the successes of rolling out syph-
ilis POCTs in Ghana and identified challenges to the
implementation process. Although, routine syphilis screen-
ing was integrated into ANC services and decentralised,
key challenges such as inadequate training and lack of
updates/refresher courses, lack of testing guidelines and
treatment protocols, frequent stockouts/expired test kits
due in part to lack of clear communication between central
and periphery units, increased workload and poor docu-
mentation of test results and treatments in the ANC regis-
ter needed to be addressed to improve and sustain the use
of this new technology in Ghana.
Our study highlighted the benefits of decentralisation
of free antenatal syphilis screening with POCTs in this
low resource setting. Most public health facilities had
started free antenatal syphilis screening, thereby making
testing more accessible especially to the rural folks.
Since ANC coverage is high (> 90%) [8], effective rollout
of syphilis POCTs has the potential of reaching almost
all pregnant women. It is imperative that use of syphilis
POCTs must be extended to private health facilities if
the goal of achieving universal access to antenatal syphilis
screening and treatment is to be attained. In the meantime,
a policy of “mop-up” screening could be instituted at deliv-
ery where all pregnant women who were not screened dur-
ing ANC will be tested at delivery and treated as necessary;
partner notification and treatment could be offered during
postnatal visits. Whilst syphilis testing at delivery cannot
prevent vertical transmission in the index pregnancy, it pro-
vides an opportunity to offer prophylactic treatment to such
babies (unless there are signs of congenital syphilis in
which case full treatment will be required) and may prevent
vertical transmission in subsequent pregnancies. How-
ever, this does not preclude prenatal testing during fu-
ture pregnancies.
Knowledge of the policy on an intervention is a pre-
requisite for the acceptance and successful implementation
of the policy at the facility level [13]. Healthcare providers
were aware of and accepted the policy to screen all
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pregnant women for syphilis during ANC. Counselling
skills were enhanced by a good understanding of the
consequences of maternal syphilis in this study. These
findings suggest that knowledge and an understanding
of a policy/programme can greatly enhance its implementa-
tion. In South Africa, Sprague et al. [14] observed that
health workers’ poor knowledge on PMTCT resulted in in-
adequate counselling which adversely affected the PMTCT
programme.
Generally, introduction of any new technology such as
rapid syphilis POCTs should only start after sufficient
stakeholder consultation, the development of clear testing
and treatment guidelines, comprehensive training, a reli-
able test and drug supply, and establishment of clear com-
munication channels to report issues in implementation
and ensure no stockouts. Our study revealed that most
training sessions were inadequate in content, lacked prac-
tical demonstrations and refresher training workshops had
not been organised. Training sessions should include la-
boratory practical on the test procedure and interpretation
of results, how to train and assess competence of health-
care staff, supply chain procedures, stock management,
record keeping and quality control [3, 15]. Integrating
such training sessions into existing HIV PMTCT training
workshops would save cost and healthcare providers time
[15]. It must however be emphasized that similarity in the
operating principles of HIV and syphilis POCTs does
not preclude adequate training prior to rollout. As
much as possible, implementation projects should be
piloted to identify and address key challenges before
scale-up [3, 15].
On the other hand, inadequate training, insufficient
guidance and supervision and lack of a quality assur-
ance system would adversely affect the quality of testing
[3, 15]. Both ANC and laboratory staff recognised the
need to complement one another’s effort to improve
testing but no quality assurance and monitoring sys-
tems were in place to monitor the performance of the
programme.
Refresher training is an essential component of any
programme implementation and has been shown to im-
pact positively on scale-up of antenatal syphilis screen-
ing [3, 16]. Given the insufficiency of the initial training
workshops, refresher courses should have been inte-
grated into regular PMTCT workshops to update and
improve staff knowledge and skill in the use of syphilis
POCTs.
Guidelines for testing and treatment protocols are im-
portant aspects of syphilis POCTs rollout. As much as pos-
sible these should be standardized with those for PMTCT
to simplify procedures for staff, ensure consistency and ease
of implementation and provide quality care to clients [15].
Luckily, national testing guidelines and treatment protocols
for HIV were available in most facilities; these could have
been adapted for syphilis testing and treatment. Notwith-
standing the similarity in testing procedures, treatment pro-
tocols for HIV and syphilis are quite different emphasizing
the need to provide separate clear guidelines for syphilis
treatment or remind healthcare staff to refer to the Ministry
of Health’s Standard Treatment Guidelines [17] during
training sessions. For example, the Standard Treatment
Guidelines recommends a single dose of 2.4 M units (MU)
of benzathine penicillin for all stages of syphilis [17], and
not the multiple and variable doses that were being given in
some facilities. Lack of screening and treatment guidelines
adversely affected the implementation of antenatal syphilis
screening in Kenya and Bolivia [18].
Interruptions in the supply of syphilis POCTs and penicil-
lin resulted in missed opportunities to prevent congenital
syphilis. Our study provides insights into how lack of clear
communication channels and poor monitoring and super-
vision adversely affected implementation of the programme.
Shortages in syphilis test kits were attributed to expired
tests kits and failure to replenish stocks. Interestingly,
healthcare providers and programme coordinators blamed
each other for stockouts. This demonstrates a lack of clear
communication channels and inadequate monitoring and
supervision of the programme; factors which were partly
responsible for poor implementation of the policy previ-
ously [5]. Discussing supply chain procedures and stock
management during training sessions and linking the pro-
curement of syphilis-related stocks to those of PMTCT
could have resulted in a more consistent supply of syphilis
test kits and penicillin [3, 19], as stockouts of HIV test kits
were reported to be less frequent.
In an earlier study in Mozambique, Gloyd et al. [16] re-
ported that the existence of multiple registers coupled with
workload impacted negatively on the recording of syphilis
test results and other interventions in the ANC register. Un-
fortunately, syphilis treatment uptake could not be evaluated
in this study due to the absence of a column for syphilis
treatment in the ANC register. However, contemporary
studies from Uganda and Zambia have demonstrated that
ANC registers can be modified to record antenatal syphilis
screening and treatment by adding extra columns [15].
Moreover, keeping a single “integrated register” makes re-
cording easier for providers, saves time and makes it simpler
to monitor integrated programmes concurrently [15].
In most low-income countries, inadequate numbers of
staff and workload can be key challenges during the imple-
mentation of priority interventions [19, 20]. There is often
the need to provide fiscal and/or non-monetary incentives
[20, 21]. Following the rollout of syphilis POCTs, healthcare
staff felt the need to be motivated and suggested both
financial and non-financial incentives such as refresher
workshops/further training, emphasising the need to
consider motivation beyond money. Refresher training
has the additional benefit of improving staff knowledge
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and skill in the particular intervention. Therefore, the
appropriate mix of incentives should be identified to
maximize staff satisfaction.
It is worth noting that healthcare providers were positive
about using new dual syphilis test kits, indicating their will-
ingness to embrace the newer technology. HIV/syphilis
dual test kits will strengthen integration of both tests into
ANC and ensure that pregnant women are screened for
both infections at the same time. The new dual trepo-
nemal/non-treponemal POCTs [22] will be very useful at
antenatal clinics in the country especially in areas endemic
for yaws. These dual test kits can correctly identify infection
status (active, past/treated or absent) within a few minutes
and avoid overtreatment of past/treated infections [22].
The study had a number of limitations. First, the se-
lection of three regions (out of 10) may not have ad-
equately reflected on the countrywide experience of
syphilis POCTs rollout. Nonetheless, the three regions
were geographically representative and reflect differ-
ent levels of maternal syphilis seroprevalence in the
country, which in turn may have impacted on levels of
interest and proficiency in syphilis testing. Second, one of
the three regional STI coordinators was not available for
interview; coincidentally, this was in the region with the
lowest syphilis prevalence. Although his experiences
would have been helpful, the other two coordinators gave
a fair idea of the implementation and collaboration be-
tween the Regional, District and facility levels. Third, it is
possible that the presence of the research team especially
the main investigator, could have modified staff attitude
and practice as a result of being observed or resulted in
self-censoring answers (the so-called ‘Hawthorne effect’)
[23]. Although this study was conducted a while ago, the
general lessons are useful for the introduction of any new
technology within the health systems of countries like
Ghana. Meanwhile, some remedial action has been taken;
the two facilities that hitherto were not offering antenatal
syphilis screening have started using syphilis POCTs. Also,
a new ANC register with a column for syphilis treatment
is in the pipeline. However, major challenges relating to
stockouts of and expired test kits, availability of ben-
zathine penicillin, testing and treatment guidelines, clear
communication channels, retraining and monitoring and
supervision largely remain unresolved.
Conclusion
Although syphilis POCTs were integrated into ANC ser-
vices, it appears the rollout focused on the purchase and
distribution of test kits and drugs, and preliminary train-
ing of healthcare providers; which were largely rushed
and perhaps inadequate to meet the challenges of a sus-
tainable programme. Key challenges particularly around
supply chain management procedures, establishment of
clear channels of communication, quality assurance and
supervision needed to be addressed to improve and sus-
tain the programme. New technologies can make an
impact when existing challenges are addressed first. A
review of the rollout as well as addressing the major
challenges identified above would greatly improve the
programme.
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